AngioDynamics, Inc. Revenue Breakdown
No Revenue Breakdown for ANGO on this site yet.
- 2026-05-31: Others Not split by product in the filing$320.17M100.00%; Total revenue $320.17M.
- 2025-05-31: Others Not split by product in the filing$292.50M100.00%; Total revenue $292.50M.
- 2024-05-31: Others Not split by product in the filing$303.91M100.00%; Total revenue $303.91M.
- 2023-05-31: Others Not split by product in the filing$338.75M100.00%; Total revenue $338.75M.
Source checked: the stored Revenue Breakdown page for ANGO.
Revenue by product
Each year (12 month)
| Fiscal year end | Others | Total revenue |
|---|---|---|
| 2026-05-31 | Not split by product in the filing $320.17M 100.00% | $320.17M |
| 2025-05-31 | Not split by product in the filing $292.50M 100.00% | $292.50M |
| 2024-05-31 | Not split by product in the filing $303.91M 100.00% | $303.91M |
| 2023-05-31 | Not split by product in the filing $338.75M 100.00% | $338.75M |
| 2022-05-31 | Not split by product in the filing $316.22M 100.00% | $316.22M |
| 2021-05-31 | Not split by product in the filing $291.01M 100.00% | $291.01M |
| 2020-05-31 | Not split by product in the filing $264.16M 100.00% | $264.16M |
| 2019-05-31 | Not split by product in the filing $270.63M 100.00% | $270.63M |
| 2018-05-31 | Not split by product in the filing $261.65M 100.00% | $261.65M |
| 2017-05-31 | Not split by product in the filing $269.79M 100.00% | $269.79M |
| 2016-05-31 | Not split by product in the filing $353.89M 100.00% | $353.89M |
| 2015-05-31 | Not split by product in the filing $356.53M 100.00% | $356.53M |
| 2014-05-31 | Not split by product in the filing $354.43M 100.00% | $354.43M |
| 2013-05-31 | Not split by product in the filing $341.92M 100.00% | $341.92M |
| 2012-05-31 | Not split by product in the filing $221.92M 100.00% | $221.92M |
| 2011-05-31 | Not split by product in the filing $215.62M 100.00% | $215.62M |
| 2010-05-31 | Not split by product in the filing $216.03M 100.00% | $216.03M |
Each quarter (3 month)
| Quarter end | Others | Total revenue |
|---|---|---|
| 2026-05-31 | Not split by product $86.61M 100.00% | $86.61M |
| 2026-02-28 | Not split by product $78.42M 100.00% | $78.42M |
| 2025-11-30 | Not split by product $79.43M 100.00% | $79.43M |
| 2025-08-31 | Not split by product $75.71M 100.00% | $75.71M |
| 2025-05-31 | Not split by product $80.16M 100.00% | $80.16M |
| 2025-02-28 | Not split by product $72.00M 100.00% | $72.00M |
| 2024-11-30 | Not split by product $72.84M 100.00% | $72.84M |
| 2024-08-31 | Not split by product $67.49M 100.00% | $67.49M |
| 2024-05-31 | Not split by product $70.98M 100.00% | $70.98M |
| 2024-02-29 | Not split by product $75.18M 100.00% | $75.18M |
| 2023-11-30 | Not split by product $79.07M 100.00% | $79.07M |
| 2023-08-31 | Not split by product $78.68M 100.00% | $78.68M |
| 2023-05-31 | Not split by product $91.07M 100.00% | $91.07M |
| 2023-02-28 | Not split by product $80.71M 100.00% | $80.71M |
| 2022-11-30 | Not split by product $85.43M 100.00% | $85.43M |
| 2022-08-31 | Not split by product $81.54M 100.00% | $81.54M |
| 2022-05-31 | Not split by product $87.00M 100.00% | $87.00M |
| 2022-02-28 | Not split by product $73.97M 100.00% | $73.97M |
| 2021-11-30 | Not split by product $78.28M 100.00% | $78.28M |
| 2021-08-31 | Not split by product $76.97M 100.00% | $76.97M |
| 2021-05-31 | Not split by product $76.84M 100.00% | $76.84M |
| 2021-02-28 | Not split by product $71.18M 100.00% | $71.18M |
| 2020-11-30 | Not split by product $72.77M 100.00% | $72.77M |
| 2020-08-31 | Not split by product $70.22M 100.00% | $70.22M |
| 2020-05-31 | Not split by product $58.33M 100.00% | $58.33M |
| 2020-02-29 | Not split by product $69.78M 100.00% | $69.78M |
| 2019-11-30 | Not split by product $70.00M 100.00% | $70.00M |
| 2019-08-31 | Not split by product $66.04M 100.00% | $66.04M |
| 2019-05-31 | Not split by product $71.18M 100.00% | $71.18M |
| 2019-02-28 | Not split by product $65.52M 100.00% | $65.52M |
| 2018-11-30 | Not split by product $69.98M 100.00% | $69.98M |
| 2018-08-31 | Not split by product $63.94M 100.00% | $63.94M |
| 2018-05-31 | Not split by product $66.19M 100.00% | $66.19M |
| 2018-02-28 | Not split by product $63.94M 100.00% | $63.94M |
| 2017-11-30 | Not split by product $66.62M 100.00% | $66.62M |
| 2017-08-31 | Not split by product $64.91M 100.00% | $64.91M |
| 2017-05-31 | Not split by product $86.91M 100.00% | $86.91M |
| 2017-02-28 | Not split by product $85.60M 100.00% | $85.60M |
| 2016-11-30 | Not split by product $89.03M 100.00% | $89.03M |
| 2016-08-31 | Not split by product $88.10M 100.00% | $88.10M |
| 2016-05-31 | Not split by product $93.42M 100.00% | $93.42M |
| 2016-02-29 | Not split by product $87.43M 100.00% | $87.43M |
| 2015-11-30 | Not split by product $89.28M 100.00% | $89.28M |
| 2015-08-31 | Not split by product $83.75M 100.00% | $83.75M |
| 2015-05-31 | Not split by product $90.70M 100.00% | $90.70M |
| 2015-02-28 | Not split by product $86.60M 100.00% | $86.60M |
| 2014-11-30 | Not split by product $92.15M 100.00% | $92.15M |
| 2014-08-31 | Not split by product $87.09M 100.00% | $87.09M |
| 2014-05-31 | Not split by product $94.06M 100.00% | $94.06M |
| 2014-02-28 | Not split by product $88.19M 100.00% | $88.19M |
| 2013-11-30 | Not split by product $92.15M 100.00% | $92.15M |
| 2013-08-31 | Not split by product $87.33M 100.00% | $87.33M |
| 2013-05-31 | Not split by product $94.06M 100.00% | $94.06M |
| 2013-02-28 | Not split by product $88.15M 100.00% | $88.15M |
| 2012-11-30 | Not split by product $88.57M 100.00% | $88.57M |
| 2012-08-31 | Not split by product $83.64M 100.00% | $83.64M |
| 2012-05-31 | Not split by product $57.69M 100.00% | $57.69M |
| 2012-02-29 | Not split by product $51.57M 100.00% | $51.57M |
| 2011-11-30 | Not split by product $58.10M 100.00% | $58.10M |
| 2011-08-31 | Not split by product $54.43M 100.00% | $54.43M |
| 2011-08-30 | Not split by product $54.43M 100.00% | $54.43M |
| 2011-05-31 | Not split by product $56.09M 100.00% | $56.09M |
| 2011-02-28 | Not split by product $54.65M 100.00% | $54.65M |
| 2010-11-30 | Not split by product $53.37M 100.00% | $53.37M |
| 2010-08-31 | Not split by product $51.51M 100.00% | $51.51M |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B | |
| SS Innovations International, Inc. (SSII) | $0.589B | -64.06 | |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| NeuroPace Inc (NPCE) | United States | $0.480B | -28.52 |
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |